B
BioEast BioTech
Core raw materials for in-vitro diagnostic reagents
About BioEast BioTech
Hangzhou Bioeast Biotech Co., Ltd. is a high-tech enterprise established in 2018, specializing in the research, development, and manufacturing of key raw materials for the in-vitro diagnostic (IVD), life science, and biomedical sectors. The company is headquartered in Hangzhou, China.
Bioeast Biotech provides a comprehensive portfolio of products, including nano microspheres, magnetic beads, antigens, antibodies, enzymes, active proteins, and chromatographic products. These materials are essential components for various diagnostic platforms such as Chemiluminescence Immunoassay (CLIA), ELISA, Lateral Flow, and Molecular Diagnostics. The business serves manufacturers of diagnostic reagents by supplying these core materials and integrated solutions, operating with an ISO13485 certified quality system to ensure product quality. It has raised a total of $40 million in funding from investors including Heda Ventures, ZJVC Venture Capital, and China Growth Capital.
The company is expanding its global reach with three wholly-owned subsidiary companies: AICHEK for Point-of-Care Testing (POCT) integrated solutions, Acnovia for Cell and Gene Therapy (CGT) integrated solutions, and BiogenMicro for chromatographic media solutions, aiming to serve a wider range of manufacturing needs.
Source: Dealroom company dataNews
Open roles
BioEast BioTech in the Hangzhou ecosystem
The BioEast BioTech office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A1 investor entered at this stage
LYFE Capital
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about BioEast BioTech on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See BioEast BioTech on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

